These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12955020)

  • 1. The effects of manipulation of puberty on growth.
    Lee PA
    Horm Res; 2003; 60(Suppl 1):60-7. PubMed ID: 12955020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined use of growth hormone and gonadotropin-releasing hormone analogues: the national cooperative growth study experience.
    Kohn B; Julius JR; Blethen SL
    Pediatrics; 1999 Oct; 104(4 Pt 2):1014-8. PubMed ID: 10506254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose effects of growth hormone during puberty.
    Saenger P
    Horm Res; 2003; 60(Suppl 1):52-7. PubMed ID: 12955018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Beneficial Effect of Combined GH/GnRHa Therapy in Increasing Adult Height Outcome in Children With ISS.
    Lazar L; Levy S; Oron T; Meyerovitch J; de Vries L; Shalitin S; Tenenbaum A; Phillip M; Lebenthal Y
    J Clin Endocrinol Metab; 2019 Aug; 104(8):3287-3295. PubMed ID: 30912806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should Skeletal Maturation Be Manipulated for Extra Height Gain?
    Wit JM
    Front Endocrinol (Lausanne); 2021; 12():812196. PubMed ID: 34975773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The KIGS experience with the addition of gonadotropin-releasing hormone agonists to growth hormone (GH) treatment of children with idiopathic GH deficiency.
    Reiter EO; Lindberg A; Ranke MB; Price DA; Albertsson-Wikland K; Cowell CT; Bakker B
    Horm Res; 2003; 60(Suppl 1):68-73. PubMed ID: 12955021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for maximizing growth in puberty in children with short stature.
    Mauras N
    Pediatr Clin North Am; 2011 Oct; 58(5):1167-79, x. PubMed ID: 21981954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short Adult Height After Rapid-tempo Puberty: When is it too Late to Treat?
    Lee PA
    J Clin Res Pediatr Endocrinol; 2024 May; 16(2):235-242. PubMed ID: 38828521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for maximizing growth in puberty in children with short stature.
    Mauras N
    Endocrinol Metab Clin North Am; 2009 Sep; 38(3):613-24. PubMed ID: 19717007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth of short normal children in puberty treated for 3 years with growth hormone alone or in association with gonadotropin-releasing hormone agonist.
    Job JC; Toublanc JE; Landier F
    Horm Res; 1994; 41(5-6):177-84. PubMed ID: 7959618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth Hormone With Aromatase Inhibitor May Improve Height in CYP11B1 Congenital Adrenal Hyperplasia.
    Hawton K; Walton-Betancourth S; Rumsby G; Raine J; Dattani M
    Pediatrics; 2017 Feb; 139(2):. PubMed ID: 28126912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature.
    Yanovski JA; Rose SR; Municchi G; Pescovitz OH; Hill SC; Cassorla FG; Cutler GB
    N Engl J Med; 2003 Mar; 348(10):908-17. PubMed ID: 12621135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approach to the Peripubertal Patient With Short Stature.
    Torres-Santiago L; Mauras N
    J Clin Endocrinol Metab; 2024 Jun; 109(7):e1522-e1533. PubMed ID: 38181434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel approaches to short stature therapy.
    Wit JM; Oostdijk W
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):353-66. PubMed ID: 26051296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low growth hormone levels are related to increased body mass index and do not reflect impaired growth in luteinizing hormone-releasing hormone agonist-treated children with precocious puberty.
    Kamp GA; Manasco PK; Barnes KM; Jones J; Rose SR; Hill SC; Cutler GB
    J Clin Endocrinol Metab; 1991 Feb; 72(2):301-7. PubMed ID: 1991801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
    Pasquino AM; Pucarelli I; Segni M; Matrunola M; Cerroni F
    J Clin Endocrinol Metab; 1999 Feb; 84(2):449-52. PubMed ID: 10022399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
    Boepple PA; Mansfield MJ; Wierman ME; Rudlin CR; Bode HH; Crigler JF; Crawford JD; Crowley WF
    Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mathematical model for total pubertal growth in idiopathic growth hormone (GH) deficiency suggests a moderate role of GH dose.
    Ranke MB; Lindberg A; Martin DD; Bakker B; Wilton P; Albertsson-Wikland K; Cowell CT; Price DA; Reiter EO
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4748-53. PubMed ID: 14557450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of combined treatment with growth hormone and gonadotropin releasing hormone analogue in children with poor prognosis of adult height.
    Toumba M; Bacopoulou I; Savva SC; Skordis N
    Indian Pediatr; 2007 Jul; 44(7):497-502. PubMed ID: 17684302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precocious puberty and statural growth.
    Carel JC; Lahlou N; Roger M; Chaussain JL
    Hum Reprod Update; 2004; 10(2):135-47. PubMed ID: 15073143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.